Sophiris Bio, Inc.
SPHS
SPHS was delisted on the 11th of March, 2020.
31 hedge funds and large institutions have $5.18M invested in Sophiris Bio, Inc. in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 5 closing their positions.
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
3% more funds holding
Funds holding: 30 → 31 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
10% less capital invested
Capital invested by funds: $5.77M → $5.18M (-$596K)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $235K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$434K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$59.4K |
| 3 |
Millennium Management
New York
|
+$38.1K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$31.9K |
| 5 |
JP Morgan Chase
New York
|
+$15.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$491K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$420K |
| 3 |
AL
Airain Ltd
St. Peter Port,
Guernsey
|
-$100K |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$90K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$50.5K |
SPHS Hedge Fund Activity: Q1 2017 in Review
31 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Sophiris Bio, Inc. (SPHS) for Q1 2017, worth a combined $5.18M — down 10% from $5.77M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new SPHS positions and 5 closed out — a net gain of 1 holder — while 6 added to existing stakes and 6 trimmed.
The largest buyer was Vanguard Group, adding an estimated $434K. The largest seller was Oxford Asset Management, exiting entirely with an estimated $491K sold.
- 31 institutional investors held Sophiris Bio, Inc. (SPHS) as of Q1 2017, up from 30 in Q4 2016.
- Funds reported $5.18M of Sophiris Bio, Inc. stock for Q1 2017, down 10% quarter-over-quarter.
- 6 funds opened new Sophiris Bio, Inc. positions in Q1 2017 and 5 closed out, a net change of +1 holder.
- The largest Sophiris Bio, Inc. buyer in Q1 2017 was Vanguard Group, an estimated $434K added.
- The largest Sophiris Bio, Inc. seller in Q1 2017 was Oxford Asset Management, an estimated $491K sold.
Based on aggregated 13F filings for Q1 2017.